Work

A single arm phase 2 study of talimogene laherparepvec in patients with low-risk invasive cutaneous squamous cell cancer. interim analysis.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e21583

Authors: Clara N Curiel, Delaney Stratton, Haiyan Cui, Denise Roe, Hina Arif Tiwari, Srinath Sundararajan

Institutions: University of Arizona Cancer Center, University of Arizona

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W4281765290

Cites:

Cited by: 11

Related to: 10